
Blog
Clinical Trials Round-Up: March 2017
by Najee Boucher
New clinical trials for brain tumors and metastases are currently open for enrollment at the Pacific Neuroscience Institute. Contact us at 310-829-8265.
Clinical Trials Round-Up: February 2017
by Zara Jethani
Our clinical trials roster includes a NASA-affiliated study to help astronauts stay healthy during longer space travel. Read more for eligibility criteria for all our trials.
Clinical Trials Round-Up: January 2017
by Zara Jethani
We have added a new clinical trial and a dose expansion cohort to our roster of brain tumor clinical trials at the Pacific Neuroscience Research Center at Pacific Neuroscience Institute. TRIALS OPEN FOR ENROLLMENT: New Trial Triphase MRZ-112 (NCT02903069): Study of Marizomib With Temozolomide and Radiotherapy in Patients...
Clinical Trials Round-Up: December 2016
by Zara Jethani
We have added a new clinical trial to our roster of brain tumor trials at the Pacific Neuroscience Research Center at PNI. NEW CLINICAL TRIAL Orbus Therapeutics (NCT02796261): A Randomized Phase 3 Open-Label Study To Evaluate the Efficacy and Safety of Eflornithine With Lomustine Compared to Lomustine...
Clinical Trials Round-Up: November 2016
by Zara Jethani
We have recently added a new clinical trial protocol at the Pacific Neuroscience Research Center at PNI. NEW CLINICAL TRIAL Boehringer Ingelheim (NCT 02423525): A Phase I Dose Escalation and CNS Pharmacokinetic Study of the ErbB Family Inhibitor Afatinib in Patients with Recurrent or Progressive Brain...
Clinical Trials Round-Up: September 2016
by Zara Jethani
We are pleased to announce a new clinical trial protocol that is now available at the Pacific Neuroscience Research Center at PNI. NEW CLINICAL TRIAL Inspyr Therapeutics (NCT 02876003):Efficacy, Safety and CNS Exposure of G-202 in Patients with PSMA-Positive Recurrent or Progressive Glioblastoma. Glioblastoma (GBM)...
Clinical Trials Round-Up: August 2016
by Zara Jethani
We have added two new clinical trials to our roster. NEW CLINICAL TRIALS AbbVie / RTOG (NCT 02573324): A Study of ABT-414 in Subjects With Newly Diagnosed Glioblastoma (GBM) With Epidermal Growth Factor Receptor (EGFR) Amplification. This study seeks to determine whether the addition of...
Clinical Trials Round-Up: May 2016
by Zara Jethani
We have a number of ongoing and new clinical trials at the Pacific Brain Tumor Center for patients who may benefit from newer brain tumor treatment options. In our Clinical Trials Round-Up blog series, we will periodically provide an update on the latest clinical trials and studies at our center....
Last updated: November 13th, 2019